Report for Son MH

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (5)

Title : Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models - Kim_2017_Arch.Pharm.Res_40_268
Author(s) : Kim MK , Chae YN , Ahn GJ , Shin CY , Choi SH , Yang EK , Sohn YS , Son MH
Ref : Arch Pharm Res , 40 :268 , 2017
Abstract : Kim_2017_Arch.Pharm.Res_40_268
ESTHER : Kim_2017_Arch.Pharm.Res_40_268
PubMedSearch : Kim_2017_Arch.Pharm.Res_40_268
PubMedID: 27885461

Title : Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes - Kim_2016_Eur.J.Pharmacol_771_65
Author(s) : Kim TH , Kim MK , Cheong YH , Chae YN , Lee Y , Ka SO , Jung IH , Shin CY , Bae EJ , Son MH
Ref : European Journal of Pharmacology , 771 :65 , 2016
Abstract : Kim_2016_Eur.J.Pharmacol_771_65
ESTHER : Kim_2016_Eur.J.Pharmacol_771_65
PubMedSearch : Kim_2016_Eur.J.Pharmacol_771_65
PubMedID: 26621343

Title : DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes - Kim_2012_Life.Sci_90_21
Author(s) : Kim MK , Chae YN , Kim HD , Yang EK , Cho EJ , Choi SH , Cheong YH , Kim HS , Kim HJ , Jo YW , Son MH , Kim SH , Shin CY
Ref : Life Sciences , 90 :21 , 2012
Abstract : Kim_2012_Life.Sci_90_21
ESTHER : Kim_2012_Life.Sci_90_21
PubMedSearch : Kim_2012_Life.Sci_90_21
PubMedID: 22056373

Title : A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis - Cho_2011_Diabetes.Res.Clin.Pract_91_72
Author(s) : Cho JM , Jang HW , Cheon H , Jeong YT , Kim DH , Lim YM , Choi SH , Yang EK , Shin CY , Son MH , Kim SH , Kim HJ , Lee MS
Ref : Diabetes Res Clin Pract , 91 :72 , 2011
Abstract : Cho_2011_Diabetes.Res.Clin.Pract_91_72
ESTHER : Cho_2011_Diabetes.Res.Clin.Pract_91_72
PubMedSearch : Cho_2011_Diabetes.Res.Clin.Pract_91_72
PubMedID: 21093089

Title : Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes - Kim_2011_Bioorg.Med.Chem.Lett_21_3809
Author(s) : Kim HJ , Kwak WY , Min JP , Lee JY , Yoon TH , Kim HD , Shin CY , Kim MK , Choi SH , Kim HS , Yang EK , Cheong YH , Chae YN , Park KJ , Jang JM , Choi SJ , Son MH , Kim SH , Yoo M , Lee BJ
Ref : Bioorganic & Medicinal Chemistry Lett , 21 :3809 , 2011
Abstract : Kim_2011_Bioorg.Med.Chem.Lett_21_3809
ESTHER : Kim_2011_Bioorg.Med.Chem.Lett_21_3809
PubMedSearch : Kim_2011_Bioorg.Med.Chem.Lett_21_3809
PubMedID: 21570283